138 related articles for article (PubMed ID: 10644014)
1. The effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brain.
Amicarelli F; Gasbarri A; Masciocco L; Pompili A; Pacitti C; Carlucci G; Palumbo G; Miranda M
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1093-7. PubMed ID: 10644014
[TBL] [Abstract][Full Text] [Related]
2. Specific increase of L-dopa levels in plasma upon infusion of tyrosinase containing liposomes.
Miranda M; Amicarelli F; Volpe AR; Poma A; Masciocco L; Carmignani M
Gen Pharmacol; 1993 Nov; 24(6):1319-22. PubMed ID: 8112501
[TBL] [Abstract][Full Text] [Related]
3. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
5. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
Mura A; Feldon J; Mintz M
Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
[TBL] [Abstract][Full Text] [Related]
6. Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease.
Horellou P; Lundberg C; Le Bourdellès B; Wictorin K; Brundin P; Kalén P; Björklund A; Mallet J
J Physiol (Paris); 1991; 85(3):158-70. PubMed ID: 1687823
[TBL] [Abstract][Full Text] [Related]
7. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
8. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
[TBL] [Abstract][Full Text] [Related]
11. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA
J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
[TBL] [Abstract][Full Text] [Related]
12. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
Ugriumov MV
Usp Fiziol Nauk; 2007; 38(4):3-20. PubMed ID: 18064905
[TBL] [Abstract][Full Text] [Related]
13. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
17. Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Nagatsu T
Toxicology; 2005 Dec; 216(1):9-14. PubMed ID: 16115719
[TBL] [Abstract][Full Text] [Related]
18. Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
Carlsson T; Winkler C; Burger C; Muzyczka N; Mandel RJ; Cenci A; Björklund A; Kirik D
Brain; 2005 Mar; 128(Pt 3):559-69. PubMed ID: 15659429
[TBL] [Abstract][Full Text] [Related]
19. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy for Parkinson's disease: studies in animal models].
Muramatsu S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
